...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?
【24h】

Pain management index (PMI)-does it reflect cancer patients' wish for focus on pain?

机译：疼痛管理指数（PMI） - 它反映癌症患者的临界关注疼痛吗？

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background The pain management index (PMI) was developed to combine information about the prescribed analgesics and the self-reported pain intensity in order to assess physicians' response to patients' pain. However, PMI has been used to explore undertreatment of cancer pain. The present study explores prevalence of negative PMI and its associations to clinical variables, including the patient-perceived wish for more attention to pain. Methods A single-center, cross-sectional, observational study of cancer patients was conducted. Data on demographics and clinical variables, as well as patient-perceived wish for more attention to pain, were registered. PMI was calculated. Negative PMI indicates that the analgesics prescribed might not be appropriate to the pain intensity reported by the patient, and associations to negative PMI were explored by logistic regression models. Results One hundred eighty-seven patients were included, 53% had a negative PMI score. Negative PMI scores were more frequent among patients with breast cancer (OR 4.2, 95% CI 1.3, 13.5), in a follow-up setting (OR 12.1, 95% CI 1.4, 101.4), and were inversely associated to low performance status (OR 0.14, 95% CI 0.03, 0.65). Twenty-two percent of patients with negative PMI scores reported that they wanted more focus on pain management, versus 13% among patients with a non-negative PMI score; the difference was not statistically significant. Conclusion A high prevalence of negative PMI was observed, but only 1/5 of patients with a negative PMI wanted more attention to pain by their physician. Our findings challenge the use of PMI as a measure of undertreatment of cancer pain.
机译：背景技术止痛管理指数（PMI）是制定的，以结合有关规定的镇痛药和自我报告的疼痛强度的信息，以评估医生对患者疼痛的反应。然而，PMI已被用于探索癌症疼痛的疾病。本研究探讨了负PMI及其与临床变量的关联的患病率，包括患者感知的致命希望更加关注疼痛。方法对癌症患者的单中心，横截面，观察性研究进行。注册了关于人口统计学和临床​​变量的数据，以及更加关注疼痛的患者感知的愿望。 PMI计算出来。阴性PMI表明规定的镇痛药可能不适应患者报告的疼痛强度，并通过Logistic回归模型探讨了对负PMI的关联。结果包括一百八十七名患者，53％的PMI得分负。乳腺癌（或4.2,95％CI 1.3,13.5）的患者中，在后续设置（或12.1,95％CI 1.4,101.4）中，在乳腺癌（或4.2,95％CI 1.3,13.5）中更频繁地频繁频繁。与低性能状况相反（或0.14,95％CI 0.03,0.65）。 22％的负面PMI分数的患者报告说，他们希望更加注重疼痛管理，而非负面PMI评分的患者之间的13％。差异没有统计学意义。结论观察到负PMI的高普遍性，但只有1/5的负面PMI的患者希望更多地注意他们的医生疼痛。我们的调查结果挑战PMI的使用作为癌症疼痛的衡量标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号